A long term non-interventional registry to assess the safety and effectiveness of adalimumab in patients with moderate to severely active ulcerative colitis
A double blind randomized placebo-controlled, dose ranging study to evaluate the efficacy and safety PF -04236921 in subjects with Crohn disease who are anti-TNF inadequate responders.